Pharmacology & Pharmacokinetics Exam
2026/2027: 100 Practice Questions with
Answers on ADME, Drug Half-Life,
Anticoagulants, Antibiotics, and Clinical
Therapeutics
Description:
Master pharmacology 2026/2027 with 100 exam questions & answers. ADME, half-life,
drug interactions, anticoagulants, antibiotics.
Download the complete 2026/2027 pharmacology exam guide and pass your boards with
confidence.
,Pharmacology Exam 2026/2027: 100 ADME to NCLEX Questions
Section A: Pharmacokinetics & Drug Development
1. A student is explaining the process of drug movement through the body. In which order do
the four primary components of pharmacokinetics typically occur following oral drug
administration?
A. Metabolism, distribution, absorption, elimination
B. Absorption, distribution, metabolism, elimination
C. Distribution, absorption, elimination, metabolism
D. Absorption, metabolism, distribution, elimination
Answer: B
Explanation: Pharmacokinetics follows the sequence of Absorption (entry into plasma),
Distribution (movement to tissues), Metabolism (biotransformation), and Elimination
(removal from the body), commonly remembered by the acronym ADME.
2. A drug’s half-life is a critical parameter in clinical practice. Which statement accurately
describes drug half-life under first-order kinetics?
A. It is the time required for the drug to be completely removed from the body.
B. It is variable and depends on the initial plasma concentration of the drug.
C. It determines the time needed to reach steady state and the dosing interval.
D. It represents the rate at which a drug is metabolized by zero-order processes.
Answer: C
Explanation: Half-life under first-order kinetics is constant and directly determines how
frequently a drug must be administered. Steady state is typically achieved after 4-5 half-lives.
3. During a clinical trial, a new medication is administered intravenously. Why does this
route provide the highest bioavailability?
A. It allows for slow release of the medication into systemic circulation.
B. It completely bypasses the absorption phase and first-pass hepatic metabolism.
C. It requires the drug to be absorbed through the gastrointestinal tract.
D. It uses first-pass metabolism to activate the prodrug.
,Answer: B
Explanation: Intravenous administration places the entire dose directly into the bloodstream,
circumventing both the absorption process and the first-pass effect in the liver, resulting in
100% bioavailability.
4. A patient is receiving a drug that follows zero-order pharmacokinetics. What does this
indicate about the drug’s elimination?
A. A constant fraction of the drug is eliminated per unit of time.
B. The drug’s half-life remains constant regardless of concentration.
C. A constant amount of the drug is eliminated per unit of time.
D. The elimination rate is directly proportional to the drug concentration.
Answer: C
Explanation: Zero-order (nonlinear) kinetics means the drug is metabolized at a constant rate
per unit time (e.g., 10 mg per hour), regardless of total drug concentration. This is typical for
phenytoin or high-dose alcohol.
5. According to current FDA stages of drug development, which phase involves post-
marketing surveillance to detect rare adverse effects?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: D
Explanation: Phase IV studies are conducted after FDA approval and marketing. They focus
on long-term safety monitoring, identifying adverse effects that were too rare to be detected
in earlier clinical trials.
Section B: Adverse Drug Reactions & Medication Safety
6. A nurse reports an unexpected severe reaction to a newly prescribed medication. Which
statement best characterizes adverse drug reactions (ADRs)?
A. The FDA mandates that all ADRs be reported to the agency.
B. Over 85% of ADRs are idiosyncratic and unpredictable.
, C. ADRs are rarely preventable and seldom occur in hospital settings.
D. The majority of ADRs are pharmacological extensions of the drug’s effects.
Answer: D
Explanation: Approximately 85-90% of ADRs are pharmacological (Type A), meaning they
are predictable extensions of the drug's primary mechanism of action. Idiosyncratic reactions
are much less common.
7. Polypharmacy increases the risk of ADRs, particularly in older adults. Which situation best
exemplifies polypharmacy?
A. Using one pharmacy to fill all prescriptions.
B. Taking five different medications prescribed by a single physician.
C. Using multiple pharmacies and seeing several specialists for different conditions.
D. Taking over-the-counter medications exclusively.
Answer: C
Explanation: Polypharmacy is characterized by the use of multiple medications, often from
different prescribers and dispensed at different pharmacies, leading to increased risk of drug
interactions and non-adherence.
Section C: Cardiovascular Pharmacology
8. A patient taking lisinopril develops a persistent dry cough and hoarseness. What is the
most appropriate initial action?
A. Add a thiazide diuretic to control the cough.
B. Prescribe an antitussive medication.
C. Discontinue the ACE inhibitor and monitor for angioedema.
D. Reassure the patient that the cough will resolve with continued use.
Answer: C
Explanation: A dry cough is a common side effect of ACE inhibitors, but hoarseness can be
an early sign of angioedema, a serious adverse reaction. The drug should be discontinued,
and the patient monitored for airway compromise.
2026/2027: 100 Practice Questions with
Answers on ADME, Drug Half-Life,
Anticoagulants, Antibiotics, and Clinical
Therapeutics
Description:
Master pharmacology 2026/2027 with 100 exam questions & answers. ADME, half-life,
drug interactions, anticoagulants, antibiotics.
Download the complete 2026/2027 pharmacology exam guide and pass your boards with
confidence.
,Pharmacology Exam 2026/2027: 100 ADME to NCLEX Questions
Section A: Pharmacokinetics & Drug Development
1. A student is explaining the process of drug movement through the body. In which order do
the four primary components of pharmacokinetics typically occur following oral drug
administration?
A. Metabolism, distribution, absorption, elimination
B. Absorption, distribution, metabolism, elimination
C. Distribution, absorption, elimination, metabolism
D. Absorption, metabolism, distribution, elimination
Answer: B
Explanation: Pharmacokinetics follows the sequence of Absorption (entry into plasma),
Distribution (movement to tissues), Metabolism (biotransformation), and Elimination
(removal from the body), commonly remembered by the acronym ADME.
2. A drug’s half-life is a critical parameter in clinical practice. Which statement accurately
describes drug half-life under first-order kinetics?
A. It is the time required for the drug to be completely removed from the body.
B. It is variable and depends on the initial plasma concentration of the drug.
C. It determines the time needed to reach steady state and the dosing interval.
D. It represents the rate at which a drug is metabolized by zero-order processes.
Answer: C
Explanation: Half-life under first-order kinetics is constant and directly determines how
frequently a drug must be administered. Steady state is typically achieved after 4-5 half-lives.
3. During a clinical trial, a new medication is administered intravenously. Why does this
route provide the highest bioavailability?
A. It allows for slow release of the medication into systemic circulation.
B. It completely bypasses the absorption phase and first-pass hepatic metabolism.
C. It requires the drug to be absorbed through the gastrointestinal tract.
D. It uses first-pass metabolism to activate the prodrug.
,Answer: B
Explanation: Intravenous administration places the entire dose directly into the bloodstream,
circumventing both the absorption process and the first-pass effect in the liver, resulting in
100% bioavailability.
4. A patient is receiving a drug that follows zero-order pharmacokinetics. What does this
indicate about the drug’s elimination?
A. A constant fraction of the drug is eliminated per unit of time.
B. The drug’s half-life remains constant regardless of concentration.
C. A constant amount of the drug is eliminated per unit of time.
D. The elimination rate is directly proportional to the drug concentration.
Answer: C
Explanation: Zero-order (nonlinear) kinetics means the drug is metabolized at a constant rate
per unit time (e.g., 10 mg per hour), regardless of total drug concentration. This is typical for
phenytoin or high-dose alcohol.
5. According to current FDA stages of drug development, which phase involves post-
marketing surveillance to detect rare adverse effects?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: D
Explanation: Phase IV studies are conducted after FDA approval and marketing. They focus
on long-term safety monitoring, identifying adverse effects that were too rare to be detected
in earlier clinical trials.
Section B: Adverse Drug Reactions & Medication Safety
6. A nurse reports an unexpected severe reaction to a newly prescribed medication. Which
statement best characterizes adverse drug reactions (ADRs)?
A. The FDA mandates that all ADRs be reported to the agency.
B. Over 85% of ADRs are idiosyncratic and unpredictable.
, C. ADRs are rarely preventable and seldom occur in hospital settings.
D. The majority of ADRs are pharmacological extensions of the drug’s effects.
Answer: D
Explanation: Approximately 85-90% of ADRs are pharmacological (Type A), meaning they
are predictable extensions of the drug's primary mechanism of action. Idiosyncratic reactions
are much less common.
7. Polypharmacy increases the risk of ADRs, particularly in older adults. Which situation best
exemplifies polypharmacy?
A. Using one pharmacy to fill all prescriptions.
B. Taking five different medications prescribed by a single physician.
C. Using multiple pharmacies and seeing several specialists for different conditions.
D. Taking over-the-counter medications exclusively.
Answer: C
Explanation: Polypharmacy is characterized by the use of multiple medications, often from
different prescribers and dispensed at different pharmacies, leading to increased risk of drug
interactions and non-adherence.
Section C: Cardiovascular Pharmacology
8. A patient taking lisinopril develops a persistent dry cough and hoarseness. What is the
most appropriate initial action?
A. Add a thiazide diuretic to control the cough.
B. Prescribe an antitussive medication.
C. Discontinue the ACE inhibitor and monitor for angioedema.
D. Reassure the patient that the cough will resolve with continued use.
Answer: C
Explanation: A dry cough is a common side effect of ACE inhibitors, but hoarseness can be
an early sign of angioedema, a serious adverse reaction. The drug should be discontinued,
and the patient monitored for airway compromise.
